Exploiting Epigenome Editing in Kabuki Syndrome: a New Route Towards Gene Therapy for Rare Genetic Disorders
Clinical trial NCT03855631 · COMPLETED
Trial details
- NCT number
- NCT03855631
- Sponsor
- University Hospital, Montpellier
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-09-28
- Primary completion
- 2020-11-27
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.